NIH-funded research R21 grant

Mitochondrial protection against alcohol-related heart damage

Official title: Exploring Mitochondrial Defense Against Ethanol-Induced Dicarbonyl Stress in the Heart

Funded at Lsu Health Sciences Center · NIH-11456728 · Data updated 2026-11-12

This grant tests whether a mitochondrial protein called ES1 helps protect the heart from damage caused by long-term alcohol use.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionLsu Health Sciences Center
NIH-funded
Lab location1 site (New Orleans, United States)
Project startAugust 11, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$215,625
NIH project number1R21AA033529-01
Project IDNIH-11456728 on NIH RePORTER

Who could benefit from this research

Could help

Not a patient-involving study at this stage, but findings could translate to people with or at risk for alcohol-related cardiomyopathy in the future.

Less likely to help

The study is preclinical and does not involve current patients.

What this research studies

Chronic heavy drinking can lead to a type of non-ischemic heart failure called alcohol-associated cardiomyopathy, which involves mitochondrial problems and heart muscle changes. The project will explore whether mitochondria-wide dicarbonyl stress from alcohol exposure contributes to this damage and whether ES1 can prevent it. Researchers will study how ES1 might detoxify harmful byproducts inside heart mitochondria and whether boosting ES1 activity preserves energy production and reduces remodeling. The work uses molecular and cellular approaches to understand a mechanism that could someday guide new treatments for alcohol-related heart disease.

Why it matters

Potential benefit: If ES1 safely protects mitochondria, this could inform new strategies to prevent or lessen alcohol-related heart damage.

How similar studies have gone: Prior evidence links mitochondrial dysfunction and aldehyde stress to heart disease, but the specific protective role of ES1 in ethanol-related damage is not yet established.

Where this research is happening

  • Lsu Health Sciences Center
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Yang, Qinglin — Lsu Health Sciences Center
  • Study coordinator: Yang, Qinglin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.